-
-
-
-
-
-
-
Marker Therapeutics treats first patient with off-the-shelf T cell therapy
-
-
-
-
-
-
-
Marker Therapeutics (MRKR) Files $300M Mixed Shelf
-
-
-
-
408,184 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

